- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Australia
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 112 Pages
North America
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 90 Pages
North America
From €4323EUR$4,750USD£3,672GBP
- Report
- August 2023
- 70 Pages
Europe
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2023
- 107 Pages
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- April 2024
- 30 Pages
Global
From €2958EUR$3,250USD£2,512GBP
- Report
- January 2024
- 189 Pages
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- January 2022
- 200 Pages
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- January 2022
- 200 Pages
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- February 2024
- 180 Pages
Global
From €4523EUR$4,969USD£3,841GBP
- Report
- November 2023
- 160 Pages
Global
From €3276EUR$3,599USD£2,782GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3521EUR$3,869USD£2,991GBP
- Report
- May 2023
- 160 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- May 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more